ABSTRACT: In reality, numerous research works have begun to report the metabolic function of COVID-19 shifts. Characteristically characterised are I decline in low-density (LDL-c) and high-density (HDL-c) cholesterol lipoproteins, (later proportionate with the gravity of the symptoms), and (ii) a mild rise in the populating T-assistance cell populations (CD3+T, CD4+T) and (iii) CD8+T lymphopenia. Further, in seriously ill patients the overall counts of White Blood Cells (WBC) is considerably higher, with a macrophage activation syndrome that was supported by the existence of the bronchoalveolar monocyte recruitment chemokines.